Diabetes and weight loss drug advertising tops $1B on strength of GLP-1 brand spending
The new class of GLP-1 drug brands is driving diabetes and weight loss prescription drug advertising spending, pushing the combined category to more than …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
